XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Mar. 31, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Cash flows from operating activities              
Net loss $ (14,158) $ (17,410) $ (15,872) $ (12,242) $ (50,081) $ (42,095)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Stock-based compensation         17,180 12,528  
Depreciation and amortization         2,450 1,436  
Accounts receivable credit losses         50 0 $ 14
Accretion of discount on marketable securities         625 1,056  
Amortization of debt issuance costs         152 234  
Loss on extinguishment of debt         0 1,848  
Loss on sale and disposal of property and equipment         133 304  
Changes in operating assets and liabilities:              
Accounts receivable         (2,001) 1,060  
Inventory         (5,178) (4,545)  
Prepaid expenses and other assets         1,401 610  
Accounts payable         1,476 425  
Accrued liabilities and other         (1,087) 320  
Net cash used in operating activities         (34,880) (26,819)  
Cash flows from investing activities              
Maturities of marketable securities         90,200 107,494  
Purchases of marketable securities         (85,257) (66,678)  
Purchases of property and equipment         (7,847) (4,614)  
Net cash provided by (used in) investing activities         (2,904) 36,202  
Cash flows from financing activities              
Proceeds from debt financing         0 35,000  
Repayments of debt financing         0 (41,000)  
Payments of debt issuance costs         0 (111)  
Payments of prepayment penalty and lender fees         0 (508)  
Proceeds from issuance of common stock under employee stock purchase plan         1,199 1,566  
Proceeds from the exercise of stock options         305 2,327  
Net cash provided by (used in) financing activities         1,504 (2,726)  
Effect of exchange rate changes on cash and cash equivalents         (840) (375)  
Net increase (decrease) in cash and cash equivalents         (37,120) 6,282  
Cash and cash equivalents at              
Beginning of period   $ 63,419   $ 53,581 63,419 53,581 53,581
End of period $ 26,299   $ 59,863   26,299 59,863 $ 63,419
Supplemental disclosure of non-cash information              
Vesting of early exercised stock options         0 27  
Unpaid purchases of property and equipment         $ 593 $ 474